Atlas Trials

The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major

Clinical trial NCT02984475 · UNKNOWN

Trial details

NCT number
NCT02984475
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Beta Thalassemia Major Anemia
Start date
2016-12-01
Primary completion
2018-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.